Life is Quantum Biology Effects Explained from the Schrödinger Equation

A plant based approach was undertaken to evaluate the efficacy of a new medical Innovation or Technology based on similar activity to the circulatory system of plants. This Innovation transforms and enhances common botanical constituents so they can be used to treat COVID-19 infection and Serious or Life-threatening conditions or diseases. On the theories of traditional Chinese medicine, a systematic approach to treating patients with COVID-19 infection and serious or life-threatening illnesses is taken. The innovation is being developed as dietary supplement products for the treatment of serious or potentially fatal conditions or diseases. The findings include over a hundred Serious or Life-threatening patient medical records. The U.S. Food and Drug Administration (FDA) accepted the Innovation’s patient medical record results, which included fifty-four COVID-19 patients with Prioritized Review Expedited No.: 2020-2867 CR2020-2596 information on September 16, 2020 and twenty-seven cancer patients Cancer Survival Rate Results in (Table 1) with FDA Establishment Identification No.: 3012327979 information on March 25, 2019 as FDA-Regulated Medical Products and meet the requirement under FDA Significant Scientific Agreement standards.